Neuberger Berman Group’s Sarepta Therapeutics SRPT Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-5,530
| Closed | -$353K | – | 2109 |
|
2025
Q1 | $353K | Buy |
5,530
+1,211
| +28% | +$77.3K | ﹤0.01% | 1642 |
|
2024
Q4 | $525K | Sell |
4,319
-116,387
| -96% | -$14.2M | ﹤0.01% | 1509 |
|
2024
Q3 | $15.1M | Buy |
120,706
+32,255
| +36% | +$4.03M | 0.01% | 717 |
|
2024
Q2 | $14M | Buy |
88,451
+2,790
| +3% | +$441K | 0.01% | 717 |
|
2024
Q1 | $11.1M | Buy |
85,661
+15,520
| +22% | +$2.01M | 0.01% | 765 |
|
2023
Q4 | $6.76M | Sell |
70,141
-1,080
| -2% | -$104K | 0.01% | 839 |
|
2023
Q3 | $8.63M | Sell |
71,221
-28
| -0% | -$3.39K | 0.01% | 767 |
|
2023
Q2 | $8.16M | Buy |
71,249
+22
| +0% | +$2.52K | 0.01% | 782 |
|
2023
Q1 | $9.82M | Buy |
71,227
+66,988
| +1,580% | +$9.23M | 0.01% | 751 |
|
2022
Q4 | $549K | Sell |
4,239
-11
| -0.3% | -$1.43K | ﹤0.01% | 1418 |
|
2022
Q3 | $470K | Buy |
4,250
+105
| +3% | +$11.6K | ﹤0.01% | 1489 |
|
2022
Q2 | $311K | Buy |
4,145
+1,305
| +46% | +$97.9K | ﹤0.01% | 1626 |
|
2022
Q1 | $222K | Buy |
+2,840
| New | +$222K | ﹤0.01% | 1778 |
|
2021
Q1 | – | Sell |
-37,779
| Closed | -$6.42M | – | 1801 |
|
2020
Q4 | $6.42M | Buy |
+37,779
| New | +$6.42M | 0.01% | 859 |
|
2019
Q3 | – | Sell |
-61,500
| Closed | -$9.35M | – | 1586 |
|
2019
Q2 | $9.35M | Buy |
61,500
+1,500
| +3% | +$228K | 0.01% | 769 |
|
2019
Q1 | $7.15M | Sell |
60,000
-2,053
| -3% | -$245K | 0.01% | 792 |
|
2018
Q4 | $6.77M | Sell |
62,053
-69,500
| -53% | -$7.58M | 0.01% | 791 |
|
2018
Q3 | $21.2M | Sell |
131,553
-667
| -0.5% | -$108K | 0.02% | 630 |
|
2018
Q2 | $17.5M | Buy |
132,220
+107,042
| +425% | +$14.1M | 0.02% | 667 |
|
2018
Q1 | $1.87M | Buy |
25,178
+7,403
| +42% | +$548K | ﹤0.01% | 1036 |
|
2017
Q4 | $989K | Sell |
17,775
-7,225
| -29% | -$402K | ﹤0.01% | 1212 |
|
2017
Q3 | $1.13M | Buy |
+25,000
| New | +$1.13M | ﹤0.01% | 1120 |
|